Advanced Search Results For "LUNG cancer"
Your filters
Screening of potential microbial markers for lung cancer using metagenomic sequencing.
Publication Type: Academic Journal
Source(s): Cancer medicine [Cancer Med] 2023 Mar; Vol. 12 (6), pp. 7127-7139. Date of Electronic Publication: 2022 Dec 08.
Abstract: Introduction: Lung cancer is the most prevalent cancer with high mortality in China, and it is associated with the dysbiosis of the lung microbiome. This study attempted to screen for specific microorganisms as potential biomarkers for distinguishing b...
[Miao medicinal crossbow acupuncture therapy as adjuvant treatment for lung cancer pain: a randomized controlled trial].
Publication Type: Academic Journal
Source(s): Zhongguo zhen jiu = Chinese acupuncture & moxibustion [Zhongguo Zhen Jiu] 2023 Mar 12; Vol. 43 (3), pp. 322-6.
Abstract: Objective: To observe the clinical efficacy of Miao medicinal crossbow acupuncture therapy as adjuvant treatment for lung cancer pain based on oxycodone hydrochloride extended-release tablet.Methods: A total of 60 patients with lung cancer pain were ra...
Using Patient-Reported Outcomes Measurement Information System® (PROMIS) to Identify Physical and Psychosocial Quality of Life Issues in Lung Cancer Survivors.
Publication Type: Academic Journal
Source(s): Journal of doctoral nursing practice [J Dr Nurs Pract] 2023 Mar 01; Vol. 16 (1), pp. 22-35.
Abstract: Background: Lung cancer survivors (LCS) are living longer due to improved screening and treatment but often experience long-term treatment effects. Due to a traditionally poor prognosis, research related to LCS symptomology and associated quality of li...
Reducing Anxiety and Dyspnea via Device-Guided Breathing (RELAX): A Multi-Site Feasibility Study in Post-Treatment Lung Cancer Survivors at Community Cancer Clinics (WF-01213).
Publication Type: Academic Journal
Source(s): Integrative cancer therapies [Integr Cancer Ther] 2023 Jan-Dec; Vol. 22, pp. 15347354231164406.
Abstract: Introduction: Anxiety and dyspnea are 2 common symptoms for lung cancer survivors. Although research suggests decreasing respiration rate can reduce anxiety in several populations, potential benefits of device-guided breathing have not been studied in ...
Lung cancer screening an asbestos exposed population: Existing lung cancer risk criteria are not sufficient.
Publication Type: Academic Journal
Source(s): Respirology (Carlton, Vic.) [Respirology] 2023 Jun; Vol. 28 (6), pp. 543-550. Date of Electronic Publication: 2023 Mar 08.
Abstract: Background and Objective: Asbestos is a major risk factor for lung cancer, with or without tobacco smoke exposure. Low dose computed tomography (LDCT) screening for early lung cancer is effective but only when targeting high risk populations. This stud...
Multi-source data approach for personalized outcome prediction in lung cancer screening: update from the NELSON trial.
Publication Type: Academic Journal
Source(s): European journal of epidemiology [Eur J Epidemiol] 2023 Apr; Vol. 38 (4), pp. 445-454. Date of Electronic Publication: 2023 Mar 21.
Abstract: Trials show that low-dose computed tomography (CT) lung cancer screening in long-term (ex-)smokers reduces lung cancer mortality. However, many individuals were exposed to unnecessary diagnostic procedures. This project aims to improve the efficiency o...
The value of blood-based measures of liver function and urate in lung cancer risk prediction: A cohort study and health economic analysis.
Publication Type: Academic Journal
Source(s): Cancer epidemiology [Cancer Epidemiol] 2023 Jun; Vol. 84, pp. 102354. Date of Electronic Publication: 2023 Mar 28.
Abstract: Background: Several studies have reported associations between low-cost blood-based measurements and lung cancer but their role in risk prediction is unclear. We examined the value of expanding lung cancer risk models for targeting low-dose computed to...
Leveraging social media to increase lung cancer screening awareness, knowledge and uptake among high-risk populations (The INSPIRE-Lung Study): study protocol of design and methods of a community-based randomized controlled trial.
Publication Type: Academic Journal
Source(s): BMC public health [BMC Public Health] 2023 May 26; Vol. 23 (1), pp. 975. Date of Electronic Publication: 2023 May 26.
Abstract: Background: Lung cancer is the leading cause of cancer death for both men and women in the United States. The National Lung Screening Trial (NLST) demonstrated that low-dose computed tomography (LDCT) screening can reduce lung cancer mortality among hi...
Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts.
Publication Type: Academic Journal
Source(s): International journal of cancer [Int J Cancer] 2023 May 01; Vol. 152 (9), pp. 2002-2010. Date of Electronic Publication: 2022 Nov 05.
Abstract: The EarlyCDT-Lung test is a blood-based autoantibody assay intended to identify high-risk individuals for low-dose computed tomography lung cancer screening. However, there is a paucity of evidence on the performance of the EarlyCDT-Lung test in ever-s...
Collagen Type XI Inhibits Lung Cancer-Associated Fibroblast Functions and Restrains the Integrin Binding Site Availability on Collagen Type I Matrix.
Publication Type: Academic Journal
Source(s): International journal of molecular sciences [Int J Mol Sci] 2022 Oct 03; Vol. 23 (19). Date of Electronic Publication: 2022 Oct 03.
Abstract: The tumor microenvironment, including cancer-associated fibroblast (CAF), plays an active role in non-small cell lung cancer (NSCLC) development and progression. We previously reported that collagen type XI and integrin α11, a collagen receptor, were u...